Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism
The eVTE trial will provide high-quality, real-world evidence on the effectiveness and safety of a pragmatic intervention to implement targeted postdischarge thromboprophylaxis using decision support embedded in the electronic health record.
Authors
- Joseph R. Bledsoe (ORCID: https://orcid.org/0000-0002-3005-2878)
- Scott C. Woller (ORCID: https://orcid.org/0000-0002-2522-2705)
- Ithan D. Peltan (ORCID: https://orcid.org/0000-0003-1730-234X)
- Geoffrey D. Barnes (ORCID: https://orcid.org/0000-0002-6532-8440)
- Masarret Fazili
- Scott M. Stevens (ORCID: https://orcid.org/0000-0002-9988-1551)
- James F. Lloyd (ORCID: https://orcid.org/0009-0001-0176-1501)
- Benjamin D. Horne (ORCID: https://orcid.org/0000-0002-5779-3019)
- James L. Hellewell
- Paige S. Christensen
- Allison Butler (ORCID: https://orcid.org/0000-0003-1388-1612)
- Adam Kraft
Institutions
- Intermountain Healthcare (US)
- University of Utah (US)
- University of Michigan (US)
- Intermountain Medical Center (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.rpth.2024.102549
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Patient-Centered Outcomes Research Institute
- Janssen Pharmaceuticals